YXT.COM Stock Quote YXT - Stock Price, News, Charts, Message Board, Trades

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Home
Investing
Stocks
USA
NASDAQ
YXT.COM Group Holding Ltd (YXT) Quote

YXT.COM Group Holding Ltd (YXT)

2.3744

-0.0256

(-1.07%)

At close: November 01 4:00PM

Delayed by 15 minutes

2.3744

0.00

( 0.00% )

After Hours: 4:37PM

Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Current Price

2.3744

Bid

2.33

Ask

2.50

Volume

18,840

2.14 Day's Range 2.6029

0.00 52 Week Range 0.00

Previous Close

2.40

Open

2.51

Last Trade

Last Trade Time

16:10:09

Average Volume (3m)

-

Financial Volume

$ 44,349

VWAP

2.354

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

YXT.com Group Holding Limited Announces Change of Auditor

SUZHOU, China, Oct. 31, 2024 (GLOBE NEWSWIRE) -- YXT.com Group Holding Limited (“YXT.com” or the “Company”), a leader and disruptor of the digital corporate learning industry in China, today...

YXT.com Group Holding Limited Expands Customer Base to Include Over 200 Fortune 500 Companies in China, Reinforcing Its Leadership in Digital Learning Solutions

SUZHOU, China, Oct. 10, 2024 (GLOBE NEWSWIRE) -- YXT.com Group Holding Limited (“YXT.com” or the “Company”), a leader and disruptor of the digital corporate learning industry in China, today...

YXT.com Group Holding Limited Announces Closing of Initial Public Offering

SUZHOU, China, Aug. 22, 2024 (GLOBE NEWSWIRE) -- YXT.com Group Holding Limited (“YXT.com” or the “Company”), a leader and disruptor of the digital corporate learning industry in China, today...

YXT.com Group Holding Limited Announces Pricing of Initial Public Offering

SUZHOU, China, Aug. 16, 2024 (GLOBE NEWSWIRE) -- YXT.com Group Holding Limited (“YXT.com” or the “Company”), a leader and disruptor of the digital corporate learning industry in China, today...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
NUWENewellis Inc	$ 2.34 (72.06%)	3.06M
HRYUHanryu Holdings Inc	$ 0.298 (39.32%)	5.05M
SGDSafe and Green Development Corporation	$ 3.45 (10.93%)	100.14k
GRYPGryphon Digital Mining Inc	$ 0.5872 (10.27%)	5.64k
SONDSonder Holdings Inc	$ 2.91 (8.58%)	2.42k
EDSAEdesa Biotech Inc	$ 2.67 (-16.56%)	441.63k
EPRXEupraxia Pharmaceuticals Inc	$ 2.74 (-11.61%)	2.63k
NMHINatures Miracle Holding Inc	$ 0.101 (-10.62%)	844.34k
VEROVenus Concept Inc	$ 0.389 (-9.53%)	2.88k
FRESFresh2 Group Ltd	$ 1.85 (-9.31%)	1.3k
ELABElevai Labs Inc	$ 0.0285 (-1.38%)	7.39M
AQMSAqua Metals Inc	$ 0.1424 (3.49%)	6.41M
HRYUHanryu Holdings Inc	$ 0.298 (39.32%)	5.05M
NUWENewellis Inc	$ 2.34 (72.06%)	3.06M
CDTConduit Pharmaceuticals Inc	$ 0.092 (4.43%)	2.45M

Xunefox

Xunefox 1 minute ago

I only haven't given up cause I have $1700 dollars here I can't cash out.... well $59 now..... but anyways

getmoreshares

getmoreshares 1 minute ago

no need to prove anything to anyone-- keep them guessing.

fuagf

fuagf 2 minutes ago

B402, I have given you much expert opinion, and much fact. You have offered nothing but your own confirmation biased opinion. Not one thing. And we well know what a failed lying so-called independent you are. That's my last. You get the last word.

PennyMillions852

PennyMillions852 2 minutes ago

Yea right……

joe botts

joe botts 2 minutes ago

Sell volume was prominent over the last few months.. it's good that it seems to have abated.

ge11

ge11 2 minutes ago

(https://mailchi.mp/niocorp.com/niocorp-announces-commencement-of-proposed-underwritten-public-offering-of-common-shares-warrants?e=c005a075e7)
https://www.niocorp.com

peafunke

peafunke 2 minutes ago

I didn't get a request to vote and I'm a stock holder :(

Goes to show you they are def going to pay for those lawsuits in commons.

They've got some big payments coming up. AND when the time comes, it'll be a 1000:1 or 10000:1 RS. Personally I don't think that'll happ

PonderosaPack

PonderosaPack 2 minutes ago

would have like to know the discussion at the conference. would have most likely helped SP today. The 6th will tell the tale. I do think it's a bit odd for a Q call on election day however - not optimum timing imo.

martyDg

martyDg 3 minutes ago

We are not that far from All-time-low. Who ever think it isn't possible this year is an idiot. No news this November will trigger a sell off on december for tax write off.

PickStocks

PickStocks 3 minutes ago

Yes.....tell us how you read every document and have yet to be right that money is coming back soon if not real soon....

LucytheDog

LucytheDog 3 minutes ago

Why put out a product when people just keep giving him money??
It's actually genius........I'd like to do that, but I have morals and ethics.

Split T

Split T 3 minutes ago

LARGE GREEN,

Is that not an approximate gain of 20% in the customer base?

biowin

biowin 3 minutes ago

Convestro is Bioamber's customer, also Mitsui continued to supply Bioamber's biosuccinic acid to convestro from Asia

https://www.chemanager-online.com/en/news/bioamber-sarnia-ships-first-succinic-acid

https://www.covestro.com/press/covestro-mitsui-chemicals-and-mitsui-

exwannabe

exwannabe 3 minutes ago

Did you note the 2.3M shares printed yesterday?

Have you ever noticed any correlation between shares printed and selling into the market?

Did you notice the 10+M shares printed around 5/10/22?

Squirrely_McShitty

Squirrely_McShitty 4 minutes ago

Oh, that. Yeah, that's nothing. Did you know...

Black's brother-in-law knew a guy who once ate at the same McDonalds as Bernie Madoff?

kabunushi

kabunushi 4 minutes ago

What about dcVax plus ICL-poly? As you know both arms of the combination trial due to end in December were treated with both. I take it as known that the ICL-poly increases efficacy, just not sure yet how much so.

Steady_T

Steady_T 4 minutes ago

OLE trial can not have a placebo cohort.

Only previous trial patients are eligible and all of those patients are in the OLE to receive the drug.

An OLE trial is to provide long term safety and tolerability data.

1vman

1vman 5 minutes ago

*****🟥🟥🟥 Oh gosh oh gee ! Now I am hearing nonsense 50 - $60 is possible for DBMM ??? not even a 🟥massive reverse split 🟥can get this OTC stinky pinky stock to those numbers

With no revenues ? little assets ? convertible debt ! SMH

boi568

boi568 5 minutes ago

The transient side effects reported in the 2b/3 do not rise to the level of "important safety issues," so you can relax about that.

Nor has the administration of blarcamesine ever resulted in safety issues across multiple indications, wide age ranges, and in longitudinal studies.

Wayne R

Wayne R 6 minutes ago

Anyway, I prefer going into a trade knowing my potential loss (all of it)

getmoreshares

getmoreshares 6 minutes ago

guess you were not flipping! it dipped to .0003 and ran up to .0008-9! trade it!

aBeezlee

aBeezlee 6 minutes ago

I can't imagine having SL set for Elite... This is one of the best performing OTC in recent memory.

richme

richme 6 minutes ago

ZHUDING INTL LTD F Quantity1,405,412 Price$0.023 Price Change+$0.0015 Market Value$32,324.48
Day Change+$2,064.22 Cost Basis$33,812.96 Gain Loss-$1,488.48
This data for ZHUD directly from my Schwab account.

sortagreen

sortagreen 8 minutes ago

https://qph.cf2.quoracdn.net/main-qimg-ee7f766d91deb06b9f90d7905c32d7b1

martyDg

martyDg 8 minutes ago

All you cult members predictions are waaaaaaay off.

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions